146 related articles for article (PubMed ID: 37751309)
1. A short report of novel acute promyelocytic leukemia with runt-related transcription factor 1-retinoic acid receptor alpha.
Kong X; Hu M; Zhang J; Han J; Liu Y; Song B; Lin Z; Qiu H
Hematol Oncol; 2024 Jan; 42(1):e3214. PubMed ID: 37751309
[No Abstract] [Full Text] [Related]
2. TFG-RARA: A novel fusion gene in acute promyelocytic leukemia that is responsive to all-trans retinoic acid.
Chong ML; Cheng H; Xu P; You H; Wang M; Wang L; Ho HH
Leuk Res; 2018 Nov; 74():51-54. PubMed ID: 30292835
[No Abstract] [Full Text] [Related]
3. Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Iaccarino L; Ottone T; Hasan SK; Divona M; Cicconi L; Lavorgna S; Alfonso V; Basso G; Barragán E; Bocchia M; Rego EM; Grimwade D; Voso MT; Lo-Coco F
Leuk Lymphoma; 2018 May; 59(5):1268-1270. PubMed ID: 28838264
[No Abstract] [Full Text] [Related]
4. Differentiation therapy of acute promyelocytic leukemia.
Chen Z
Chin Med J (Engl); 1996 Mar; 109(3):179-82. PubMed ID: 8758302
[No Abstract] [Full Text] [Related]
5. Differentiation therapy using low-dose venetoclax in a variant acute promyelocytic leukaemia carrying ZBTB16-RARA.
Li H; Xiang X; Ding H; Yu J; Xu J; Yuan Y; Wu Y
Br J Haematol; 2022 Dec; 199(5):768-771. PubMed ID: 36169236
[No Abstract] [Full Text] [Related]
6. How retinoic acid and arsenic transformed acute promyelocytic leukemia therapy.
Korsos V; Miller WH
J Mol Endocrinol; 2022 Nov; 69(4):T69-T83. PubMed ID: 36112505
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel recurrent
Yao L; Wen L; Wang N; Liu T; Xu Y; Ruan C; Wu D; Chen S
Blood; 2018 Feb; 131(8):935-939. PubMed ID: 29237593
[No Abstract] [Full Text] [Related]
8. Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN.
Yao S; Zhong L; Chen M; Zhao Y; Li L; Liu L; Xu T; Xiao C; Gan L; Shan Z; Liu B
Int J Oncol; 2017 Sep; 51(3):899-906. PubMed ID: 28766684
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a rarely reported STAT5B/RARA gene fusion in a young adult with newly diagnosed acute promyelocytic leukemia with resistance to ATRA therapy.
Peterson JF; He RR; Nayer H; Cuevo RS; Smadbeck JB; Vasmatzis G; Greipp PT; Ketterling RP; Hoppman NL; Baughn LB
Cancer Genet; 2019 Sep; 237():51-54. PubMed ID: 31447065
[TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
Strehl S; König M; Boztug H; Cooper BW; Suzukawa K; Zhang SJ; Chen HY; Attarbaschi A; Dworzak MN
Leukemia; 2013 Jul; 27(7):1606-10. PubMed ID: 23271512
[No Abstract] [Full Text] [Related]
11. NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK.
Xiao C; Zhong L; Shan Z; Xu T; Gan L; Song H; Yang R; Li L; Liu B
Int J Med Sci; 2016; 13(8):611-9. PubMed ID: 27499693
[TBL] [Abstract][Full Text] [Related]
12. Isochromosome for derivative 17q in acute promyelocytic leukemia: evidence for two copies of PML-RARA and favorable response to all-trans-retinoic acid therapy.
Park JP; Fairweather RB; Mohandas TK
Genes Chromosomes Cancer; 1997 Feb; 18(2):151-3. PubMed ID: 9115966
[No Abstract] [Full Text] [Related]
13. PML/RAR alpha + ATRA = CR. A comment on acute promyelocytic leukaemia: molecular pathology and treatment.
Dyer MJ
Eur J Cancer; 1994; 30A(5):573-4. PubMed ID: 8080665
[No Abstract] [Full Text] [Related]
14. The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia.
Yang X; Zhang R; Zhang Z
Ann Hematol; 2022 Sep; 101(9):2101-2102. PubMed ID: 35704083
[No Abstract] [Full Text] [Related]
15. 2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia.
Lu Y; Yan JS; Xia L; Qin K; Yin QQ; Xu HT; Gao MQ; Qu XN; Sun YT; Chen GQ
Haematologica; 2019 Jan; 104(1):102-112. PubMed ID: 30076181
[TBL] [Abstract][Full Text] [Related]
16. Novel retinoic acid receptor-alpha transcripts in acute promyelocytic leukemia responsive to all-trans-retinoic acid.
Miller WH; Warrell RP; Frankel SR; Jakubowski A; Gabrilove JL; Muindi J; Dmitrovsky E
J Natl Cancer Inst; 1990 Dec; 82(24):1932-3. PubMed ID: 2174466
[No Abstract] [Full Text] [Related]
17. Cryptic molecular lesion in acute promyelocytic leukemia with negative initial FISH.
Singh J; Facey A; O'Malley F; Ryland GL; Blombery P; Gregory GP
Leuk Lymphoma; 2021 Dec; 62(12):3060-3062. PubMed ID: 34151721
[No Abstract] [Full Text] [Related]
18. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
[TBL] [Abstract][Full Text] [Related]
19. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
[No Abstract] [Full Text] [Related]
20. The co-expression of PML/RAR alpha and AML1/ETO fusion genes is associated with ATRA resistance.
Abreu e Lima RS; Baruffi MR; de Lima AS; de Oliveira FM; de Figueiredo-Pontes LL; Tone LG; Rogatto SR; Falcao RP; Ferrari Chauffaille Mde L; Rego EM
Br J Haematol; 2005 Feb; 128(3):407-9. PubMed ID: 15667548
[No Abstract] [Full Text] [Related]
[Next] [New Search]
